Modifications to the basement membrane protein laminin using glycolaldehyde and A2E: A model for aging in Bruch's membrane

Experimental Eye Research

Volumn 89, Issue 2, 2009, Pages 187-192

  Murdaugh, L S ^a   Dillon, J ^b   Gaillard, E R ^a,b  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

A2E; age related macular degeneration; blue light damage; Bruch's membrane; oxidative stress; reactive aldehydes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE DERIVATIVE; ARGININE; LAMININ; LYSINE; PYRIDINIUM DERIVATIVE;

ARTICLE; BRUCH MEMBRANE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IN VIVO STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN MODIFICATION; RETINA MACULA AGE RELATED DEGENERATION;

ACETALDEHYDE; AGING; BRUCH MEMBRANE; EYE PROTEINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LAMININ; LIGHT; MACULAR DEGENERATION; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PYRIDINIUM COMPOUNDS; RETINOIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 67650424023     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.03.021     Document Type: Article

References (51)

1. Ahmed M.U., Dunn J.A., et al. Oxidative degradation of glucose adducts to protein. Formation of 3-(Ne-lysino)-lactic acid from model compounds and glycated proteins. J. Biol. Chem. 263 18 (1988) 8816-8821
2. Aisenbrey S., Zhang M., et al. Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins. Invest. Ophthalmol. Vis. Sci. 47 12 (2006) 5537-5544
3. Anderson D.H., Mullins R.F., et al. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134 3 (2002) 411-431
4. Aumailley M., and Smyth N. The role of laminins in basement membrane function. J. Anat. 193 1 (1998) 1-21
5. Charonis A.S., and Tsilbary E.C. Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41 Suppl. 2 (1992) 49-51
6. Charonis A.S., Reger L.A., et al. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 39 7 (1990) 807-814
7. Dillon J.P., Wang Z., et al. Detection of Nitro-adducts by LC/MS in aged human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1399
8. Dorey C.K., Wu G., et al. Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest. Ophthalmol. Vis. Sci. 30 8 (1989) 1691-1699
9. Federoff H.J., Lawrence D., et al. Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth. Diabetes 42 4 (1993) 509-513
10. Glenn J.V., Mahaffy H., et al. AGE-modified substrate induces global gene expression changes in ARPE-19 monolayers: relevance to lysosomal dysfunction and lipofuscin accumulation. Invest. Ophthalmol. Vis. Sci. (2008)
11. Grant D.S., Kleinman H.K., et al. The role of basement membranes in vascular development. Ann. N Y Acad. Sci. 588 (1990) 61-72
12. Hageman G.S., Luthert P.J., et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20 6 (2001) 705-732
13. Haitoglou C.S., Tsilibary E.C., et al. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J. Biol. Chem. 267 18 (1992) 12404-12407
14. Handa J.T., Verzijl N., et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest. Ophthalmol. Vis. Sci. 40 3 (1999) 775-779
15. Ho T.C., and Del Priore L.V. Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 38 6 (1997) 1110-1118
16. Honda S., Farboud B., et al. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Invest. Ophthalmol. Vis. Sci. 42 10 (2001) 2419-2425
17. Hunt D.F., Yates III J.R., et al. Protein sequencing by tandem mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 83 17 (1986) 6233-6237
18. Ivert L., Keldbye H., et al. Age-related changes in the basement membrane of the retinal pigment epithelium of Rpe65/and wild-type mice. Graefes Arch. Clin. Exp. Ophthalmol. 243 3 (2005) 250-256
19. Kalfa T.A., Gerritsen M.E., et al. Altered proliferation of retinal microvascular cells on glycated matrix. Invest. Ophthalmol. Vis. Sci. 36 12 (1995) 2358-2367
20. Kanemoto T., Reich R., et al. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc. Natl. Acad. Sci. U.S.A. 87 6 (1990) 2279-2283
21. Lamb L.E., and Simon J.D. A2E: a component of ocular lipofuscin. Photochem. Photobiol. 79 2 (2004) 127-136
22. Liang F.Q., and Godley Bernard F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res. 76 4 (2003) 397-403
23. Maeda A., Maeda T., et al. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 283 39 (2008) 26684-26693
24. Mann M., and Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal. Chem. 66 24 (1994) 4390-4399
25. Moore D.J., Hussain A.A., et al. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 36 7 (1995) 1290-1297
26. Mullins R.F., Russell S.R., et al. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14 7 (2000) 835-846
27. Nagai R., Matsumoto K., et al. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49 10 (2000) 1714-1723
28. Nagaraj R.H., Biswas A., et al. The other side of the Maillard reaction. Ann. N Y Acad. Sci. 1126 (2008) 107-112
29. Nakaizumi Y. The Ultrastructure of Bruch's membrane. I. Human, Monkey, Rabbit, Guinea Pig, and Rat Eyes. Arch. Ophthalmol. 72 (1964) 380-387
30. Nakajou K., Horiuchi S., et al. Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A). Diabetologia 48 2 (2005) 317-327
31. Newsome D.A., Huh W., et al. Bruch's membrane age-related changes vary by region. Curr. Eye Res. 6 10 (1987) 1211-1221
32. Parish C.A., Hashimoto M., et al. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc. Natl. Acad. Sci. U.S.A. 95 25 (1998) 14609-14613
33. Paul R.G., and Bailey A.J. The effect of advanced glycation end-product formation upon cell-matrix interactions. Int. J. Biochem. Cell Biol. 31 6 (1999) 653-660
34. Pauleikhoff D., Barondes M.J., et al. Drusen as risk factors in age-related macular disease. Am. J. Ophthalmol. 109 1 (1990) 38-43
35. Ragauskaite L., Heckathorn R.C., et al. Environmental effects on the photochemistry of A2-E, a component of human retinal lipofuscin. Photochem. Photobiol. 74 3 (2001) 483-488
36. Reszka K., Eldred C.E., et al. The photochemistry of human retinal lipofuscin as studied by EPR. Photochem. Photobiol. 62 6 (1995) 1005-1008
37. Sarici S.U., Alpay F., et al. Comparison of the efficacy of conventional special blue light phototherapy and fiberoptic phototherapy in the management of neonatal hyperbilirubinaemia. Acta Paediatr. 88 11 (1999) 1249-1253
38. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 60 5 (1976) 324-341
39. Sparrow J.R., and Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Vis. Sci. 42 6 (2001) 1356-1362
40. Sparrow J.R., Nakanishi K., et al. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 41 7 (2000) 1981-1989
41. Sparrow J.R., Cai B., et al. A2E, a fluorophore of RPE lipofuscin: can it cause RPE degeneration?. Adv. Exp. Med. Biol. 533 (2003) 205-211
42. Stitt A.W., and Vlassara H. Advanced glycation end-products: impact on diabetic complications. In: Betteridge D.J. (Ed). Current Perspectives in Diabetes (1999), Martin Dunitz Inc., New York 67-92
43. Suter M., Reme C., et al. Age-related macular degeneration: the lipofuscin component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275 50 (2000) 39625-39630
44. Tarsio J.F., Reger L.A., et al. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association. Diabetes 37 5 (1988) 532-539
45. Tsilibary E.C., Charonis A.S., et al. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J. Biol. Chem. 263 9 (1988) 4302-4308
46. Ulrich P., and Cerami A. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 56 (2001) 1-21
47. Vlassara H., Bucala R., et al. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70 2 (1994) 138-151
48. Wang Z., Paik D.C., et al. Nitrite-Modified extracellular matrix proteins deleteriously affect retinal pigment epithelial cell function and viability: a comparison study with nonenzymatic glycation mechanisms. Curr. Eye Res. 30 8 (2005) 691-702
49. Wang Z., Keller L.M.M., et al. Oxidation of A2E results in the formation of highly reactive aldehydes and ketones. Photochem. Photobiol. 82 5 (2006) 1251-1257
50. Winkler B.S., Boulton M.E., et al. Oxidative damage and age-related macular degeneration. Mol. Vis. 5 (1999)
51. Yan S.F., Ramasamy R., et al. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ. Res. 93 12 (2003) 1159-1169